Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.

[1]  D. Kass,et al.  Ventricular-vascular interaction in heart failure. , 2011, Cardiology clinics.

[2]  B. Borlaug,et al.  Response to de Keulenaer and Brutsaert , 2011 .

[3]  G. D. De Keulenaer,et al.  Systolic and Diastolic Heart Failure Are Overlapping Phenotypes Within the Heart Failure Spectrum , 2011, Circulation.

[4]  W. Paulus,et al.  Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. , 2011, European heart journal.

[5]  R. Nishimura,et al.  Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction , 2010, Circulation. Heart failure.

[6]  V. Roger,et al.  Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. , 2009, Journal of the American College of Cardiology.

[7]  V. Roger,et al.  Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. , 2009, Journal of the American College of Cardiology.

[8]  Susan Anderson,et al.  Irbesartan in patients with heart failure and preserved ejection fraction. , 2008, The New England journal of medicine.

[9]  Margarita Lopatin,et al.  Comparison of clinical features and outcomes of patients hospitalized with heart failure and normal ejection fraction (> or =55%) versus those with mildly reduced (40% to 55%) and moderately to severely reduced (<40%) fractions. , 2008, The American journal of cardiology.

[10]  D. Kass,et al.  Impact of arterial load and loading sequence on left ventricular tissue velocities in humans. , 2007, Journal of the American College of Cardiology.

[11]  S. Solomon,et al.  Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial , 2007, The Lancet.

[12]  Wolfgang A Linke,et al.  Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure , 2006, Circulation.

[13]  N. Freemantle,et al.  Perindopril for elderly people with chronic heart failure: the PEP‐CHF study , 1999, European heart journal.

[14]  David A. Kass,et al.  Ventriculo-arterial coupling: Concepts, assumptions, and applications , 2006, Annals of Biomedical Engineering.

[15]  S. Ghio.  Pulmonary Hypertension in Advanced Heart Failure , 2005, Herz Kardiovaskuläre Erkrankungen.

[16]  T. Gillebert,et al.  Load Dependent Diastolic Dysfunction in Heart Failure , 2000, Heart Failure Reviews.

[17]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.

[18]  D. Kass,et al.  Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction: Implications for Systolic and Diastolic Reserve Limitations , 2003, Circulation.

[19]  J. C. Powers,et al.  The pathogenesis of acute pulmonary edema associated with hypertension , 2001 .

[20]  C H Chen,et al.  Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly. , 1998, Journal of the American College of Cardiology.

[21]  W. Paulus,et al.  Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. , 1994, Circulation.

[22]  K. Rootwelt,et al.  Nitroprusside and Regional Vascular Capacitance in Patients With Severe Congestive Heart Failure , 1992, Circulation.

[23]  W. Little,et al.  Left ventricular-arterial coupling in conscious dogs. , 1991, The American journal of physiology.

[24]  S Sasayama,et al.  Ventriculoarterial coupling in normal and failing heart in humans. , 1989, Circulation research.

[25]  D. Kass,et al.  From 'Emax' to pressure-volume relations: a broader view. , 1988, Circulation.

[26]  J. Lima,et al.  Modulation of vascular capacitance by angiotensin and nitroprusside: a mechanism of changes in pericardial pressure. , 1987, Circulation.

[27]  R. O'rourke,et al.  The effect of vasoactive agents on the left ventricular end-systolic pressure-volume relation in closed-chest dogs. , 1986, Circulation.

[28]  J. Carroll,et al.  The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy. , 1986, Circulation.

[29]  J. Cohn,et al.  Vasodilator Therapy of Cardiac Failure , 1977 .

[30]  J. Cohn,et al.  Vasodilator therapy of cardiac failure: (first of two parts). , 1977, The New England journal of medicine.

[31]  F. Abel,et al.  Effects of alterations in pulmonary vascular resistance on right ventricular function. , 1967, The Journal of thoracic and cardiovascular surgery.